Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The ASTAR Institute for Human Development and Potential (IHDP), formerly known as the Singapore Institute for Clinical Sciences (SICS), is a premier research institute under Singapore's Agency for Science, Technology and Research (ASTAR). IHDP focuses on translational research aimed at optimizing human potential and health across the entire life course, with specific strengths in maternal and child health, metabolic diseases, and neuroscience. The institute is renowned for managing large-scale longitudinal birth cohorts, such as GUSTO and S-PRESTO, which provide deep insights into the developmental origins of health and disease. By integrating multi-omics, clinical data, and social sciences, IHDP collaborates with global academic and industry partners to develop evidence-based interventions and policies. Its mission is to translate scientific excellence into impactful solutions that improve population health and well-being in Singapore and beyond.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Institute for Human Development and Potential.